share_log

Clovis Oncology | 8-K: Clovis Oncology Announces First Quarter 2022 Operating Results and Provides Update on Clinical Development Programs

SEC ·  May 4, 2022 20:25
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.